Important studies presented at ESOC 2016
- Baharoglu MI, Cordonnier C, Al-Shahi Salman R, de Gans K, Koopman MM, Brand A, Majoie CB, Beenen LF, Marquering HA, Vermeulen M, Nederkoorn PJ, de Haan RJ, Roos YB; PATCH INVESTIGATORS. PLATELET TRANSFUSION VERSUS STANDARD CARE AFTER ACUTE STROKE DUE TO SPONTANEOUS CEREBRAL HAEMORRHAGE ASSOCIATED WITH ANTIPLATELET THERAPY (PATCH): A RANDOMISED, OPEN-LABEL, PHASE 3 TRIAL.
- Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee TH, Broderick JP, Chen X, Chen G, Sharma VK, Kim JS, Thang NH, Cao Y, Parsons MW, Levi C, Huang Y, Olavarría VV, Demchuk AM, Bath PM, Donnan GA, Martins S, Pontes-Neto OM, Silva F, Ricci S, Roffe C, Pandian J, Billot L, Woodward M, Li Q, Wang X, Wang J, Chalmers J; ENCHANTED INVESTIGATORS AND COORDINATORS. LOW-DOSE VERSUS STANDARD-DOSE INTRAVENOUS ALTEPLASE IN ACUTE ISCHEMIC STROKE.
- Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KS; SOCRATES STEERING COMMITTEE AND INVESTIGATORS. TICAGRELOR VERSUS ASPIRIN IN ACUTE STROKE OR TRANSIENT ISCHEMIC ATTACK.
- Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW; ATACH-2 TRIAL INVESTIGATORS AND THE NEUROLOGICAL EMERGENCY TREATMENT TRIALS NETWORK. INTENSIVE BLOOD-PRESSURE LOWERING IN PATIENTS WITH ACUTE CEREBRAL HEMORRHAGE.
Follow this LINK for more ESOC 2016 studies.
